Back to User profile » Dr Hae Won Lee
Papers published by Dr Hae Won Lee:
Pharmacokinetics and Pharmacodynamics of Dapagliflozin in Obese and Nonobese Healthy Adults Following Multiple Administration
Lee HW, Kim H, Park JS, Lee JH, Park JJ, Gwon MR, Cho JY, Seong SJ, Yoon YR
Drug Design, Development and Therapy 2026, 20:574016
Published Date: 26 May 2026
A Pharmacokinetic/Pharmacodynamic Study of Esomeprazole Comparing a Dual Delayed-Release Formulation (YYD601) to a Conventional Formulation Following Multiple Administrations in Healthy Adult Subjects
Lee HW, Kang WY, Park JS, Lee JH, Park JJ, Gwon MR, Yoon YR, Seong SJ
Drug Design, Development and Therapy 2025, 19:97-110
Published Date: 8 January 2025
Pharmacokinetics and Pharmacodynamics of YYD601, a Dual Delayed-Release Formulation of Esomeprazole, Following Single and Multiple Doses in Healthy Adult Volunteers Under Fasting and Fed Conditions
Lee HW, Kang WY, Jung W, Gwon MR, Cho K, Yoon YR, Seong SJ
Drug Design, Development and Therapy 2022, 16:619-634
Published Date: 6 March 2022
A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
Kang WY, Lee HW, Gwon MR, Cho S, Shim WS, Lee KT, Yang DH, Seong SJ, Yoon YR
Drug Design, Development and Therapy 2020, 14:2101-2111
Published Date: 26 May 2020
Pharmacokinetic and bioequivalence study between two formulations of S-1 in Korean gastric cancer patients
Lee HW, Seong SJ, Kang WY, Ohk B, Gwon MR, Kim BK, Cho S, Cho K, Sung YK, Yoon YR, Kim JG
Drug Design, Development and Therapy 2019, 13:3127-3136
Published Date: 3 September 2019
Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
Kang WY, Seong SJ, Ohk B, Gwon MR, Kim BK, Cho S, Shim WS, Lee KT, Kim EH, Yang DH, Lee HW, Yoon YR
Drug Design, Development and Therapy 2018, 12:3607-3615
Published Date: 26 October 2018
Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects
Kang WY, Seong SJ, Ohk B, Gwon M, Kim BK, La S, Kim HJ, Cho S, Yoon Y, Yang DH, Lee HW
Drug Design, Development and Therapy 2018, 12:545-553
Published Date: 14 March 2018
Pharmacokinetic and safety evaluation of MB12066, an NQO1 substrate
Lee HW, Seong SJ, Ohk B, Kang WY, Gwon MR, Kim BK, Kim HJ, Yoon YR
Drug Design, Development and Therapy 2017, 11:2719-2725
Published Date: 13 September 2017